Clinical Trial

SKB103 for Injection in Advanced Solid Tumors

Name: SKB103 for Injection in Advanced Solid Tumors — clinical trial record (NCT07459998)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This is a phase 1/2 clinical study to evaluate the safety and efficacy of SKB103 in participants with advanced solid tumors. The study includes a dose escalation stage, a dose expansion stage, and a indication expansion stage.

Protocol Amendment History 1 change

critical Recruitment opened 2026-05-19

Trial Details

NCT Number	NCT07459998
Lead Sponsor	Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Conditions	Advanced Solid Tumors
Enrollment	277 participants
Start Date	2026-04-23
Primary Completion	2029-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-05-18